The role of immunochemical testing for colorectal cancer

Boncz, I; Sebestyén, Andor; Döbrőssy, Lajos; Ottó, Szabolcs

doi:10.1016/s1470-2045(06)70671-4

Cited by 17 publications

(14 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A gyógyszerek árával, ártámogatási rendszerével számos tanulmány foglalkozik [15][16][17][18][19][20], mint ahogy a magyar egészségügyi rendszer működésének [21][22][23][24] és finanszírozásának [25][26][27][28][29][30] [32][33][34][35]. Meglátásunk szerint mindez maga után vonhatja a társadalombiztosítási támogatások növelését, ami befolyásolhatja az államháztartási egyensúly fenntartását.…”

Section: Adatok éS Módszerekunclassified

Az egészségbiztosítási gyógyszerkiadások alakulása Magyarországon

2019

View full text Add to dashboard Cite

Introduction: In Hungary, health expenditures – especially the question of health insurance subsidies for medicinal products – are becoming increasingly important. Aim: The aim of our analysis is to reveal the state’s health insurance expenditure between 2010 and 2016 as well as the amount of health insurance subsidies for medicinal products. Data and methods: Data were derived from the database of the National Health Insurance Fund of Hungary and of the Hungarian Central Statistical Office. During the analysis we examined the period between 2010 and 2016. We analysed the health expenditures in proportion to the gross domestic product (GDP) as well as the changes of drug traffic based on gross consumer prices and those of health insurance subsidies, and also our regional inequalities. When writing the present study, we used descriptive statistical methods. Results: The expenditures of the National Health Insurance Fund of Hungary significantly increased as proportions of the GDP from 5.5% in 2010 to 6.1% in 2016. The health insurance subsidies for medicinal products increased since 2013. The highest health insurance subsidies per 10 000 inhabitants could be seen in Baranya (405 788 HUF/inhabitant) and Csongrád (384 724 HUF/inhabitant) counties and in Budapest (377 316 HUF/inhabitant). The lowest health insurance subsidies were found in Nógrád (289 168 HUF/inhabitant) and Szabolcs-Szatmár-Bereg (271 104 HUF/inhabitant) counties. Conclusion: The trends of health and drug expenditure show a growing tendency. We can find significant regional inequalities in case of both the drug traffic based on gross consumer prices and the health insurance subsidies. It would be needed to strengthen the elements of prevention, and to popularize health-conscious lifestyle and doing sports. Orv Hetil. 2019; 160(Suppl 1): 49–54.

show abstract

Section: Adatok éS Módszerekunclassified

Az egészségbiztosítási gyógyszerkiadások alakulása Magyarországon

2019

View full text Add to dashboard Cite

show abstract

“…The current research topics in Hungary—in line with the international literature (17;18;23;26)—covers, for example, osteoporosis and arthritis (14–16;27;28), oncology and cancer screening (4;5;9–13;25), healthcare financing (1;6–8), and coverage policy (19;20;22). In addition to the universities and research centers, the Hungarian National Health Insurance Fund Administration (Országos Egészségbiztosátási Pénztár, OEP) played an active role in the publication of scientific papers in the field of HTA.…”

mentioning

confidence: 98%

Development of health technology assessment in Central Europe

Kárpáti

Sándor

2009

Int J Technol Assess Health Care

View full text Add to dashboard Cite

Once upon a time in the 1990s, if you wanted to do HTA in the Central and Eastern European countries (CEEs), you got yourself invited by Egon Jonsson and travelled to Stockholm to learn how to do HTA. There you met him and Prof. Banta and other HTA professionals from all over the world—very importantly, motivated healthcare professionals from all CEEs who were eager to learn HTA. These eminent founding fathers were always available, and were never tired if help or assistance was needed. During that time, the telephone number of HTA was known and used extensively, making it a real, living, informal HTA network. Formal HTA collaborations organized by them and funded by the European Commission, such as EUR-ASSESS, HTA EUROPE, ECHTA/ECAHI, were also crucial . . .

show abstract

“…Hungary can be considered as a pioneer with the application of immunochemical testing for colorectal cancer. 20,21 But in Hungary we still did not have a nationwide colorectal cancer program, as it was stated in figure 3.…”

mentioning

confidence: 99%